Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2017 / Cilt: 51 - Sayı: 4

Neonatal yoksunluk sendromu ve tıbbi sosyal hizmet yönetimi

Neonatal Abstinence Syndrome and Medical Social Service Management

Pages
266–277
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, the illegal substances frequently used in pregnancy, the findings and treatment of these substances in the newborn baby, the current legal situation related to the subject in our country and the procedures of social services related to the subject were discussed and the procedures to be followed in this case were evaluated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:There is not enough data about the frequency of illegal drug use during pregnancy in developing countries and consequently the incidence of neonatal abstinence syndrome in newborn infants is unknown.
📊
Key Findings & Data:In recent years, a significant increase in the number of cases reported as neonatal abstinence syndrome has been detected in the literature.
💡
Conclusion & Impact:In this review, the illegal substances frequently used in pregnancy, the findings and treatment of these substances in the newborn baby, the current legal situation related to the subject in our country and the procedures of social services related to the subject were discussed and the procedures to be followed in this case were evaluated.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

There is not enough data about the frequency of illegal drug use during pregnancy in developing countries and consequently the incidence of neonatal abstinence syndrome in newborn infants is unknown. In recent years, a significant increase in the number of cases reported as neonatal abstinence syndrome has been detected in the literature. Due to the social and religious culture of our society, health care practitioners do not receive sufficient and accurate information from patients and their relatives. Often, this situation is revealed by the awareness of the health care practitioner. In this review, the illegal substances frequently used in pregnancy, the findings and treatment of these substances in the newborn baby, the current legal situation related to the subject in our country and the procedures of social services related to the subject were discussed and the procedures to be followed in this case were evaluated.

Özet

Gelişmekte olan ülkelerde gebelik süresince illegal ilaç kullanımı ve buna bağlı olarak yenidoğan bebeklerde neonatal yoksunluk sendromu görülme sıklığı ile ilgili yeterli veri bulunmamaktadır. Son yıllarda olgu sunumları olarak bildirilen yayınlarda önemli bir oranda artış saptanmıştır. Toplumumuzun sosyal ve inanç kültürü nedeniyle sağlık çalışanları hastadan ve hasta yakınlarından yeterli ve doğru bilgi alamamaktadır. Genellikle bu durum sağlık çalışanın farkındalığı ile ortaya konmaktadır. Konu ile ilgili derlememizde gebelikte sıklıkla kullanılan yasadışı maddeler, bu maddelerin yenidoğan bebekte saptanan bulguları ve tedavisi, ülkemizde konu ile ilgili mevcut hukuki durum ve sosyal hizmetlerin konu ile ilgili işleyiş prosedürü ele alınmış, bu durumda saptanan bebekler ile ilgili izlenmesi gereken işlemler değerlendirilmiştir.

🔖

Cite This Article

CELİKER, E. Y., CALAPCİKAY, U., USLU, S., BÜLBÜL, A. (2017). Neonatal yoksunluk sendromu ve tıbbi sosyal hizmet yönetimi. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 51 - Sayı: 4, 266–277. https://ajindex.com/articles/364037

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Jones HE, Fielder A. Neonatal abstinence syndrome: Historical perspective, current focus, future directions. Prev Med 2015; 80: 12-7. [CrossRef] 2. Tolia VN, Patrick SW, Bennett MM, Murthy K, Sousa J, Smith PB, et al. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N Engl J Med 2015; 372: 2118-26. [CrossRef] 3. Kraft WK, Stover MW, Davis JM. Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant. Semin Perinatol 2016; 40: 203-12. [CrossRef] 4. Koyuncuoglu H. The combination of tizanidine markedly improves the treatment with dextromethorphan of heroin addicted outpatients. Int J Clin Pharmacol Ther 1995; 33: 13-9. 5. Okan F, Bulbul A, Nuhoglu A. Gebelikte madde suistimali. Çocuk Dergisi 2007; 7: 76-80. 6. Can E, Bülbül A, Uslu S, Güran O, Nuhoğlu A. Neonatal yoksunluk sendromu. Ş.E.E.A.H. Tıp Bülteni 2010: 44; 124-7. 7. Kale-Çekinmez E, Mutlu B, Yapıcıoğlu H, Ozlü F, Asker H, Mert K, et al. Two newborns of heroin-addicted mothers suffering neonatal withdrawal syndrome. Turk J Pediatr 2012; 54: 421-4. 8. Özdemiroğlu N, Kara S, Kurt CC, Arıkan Fİ, Dallar Bilge Y. Neonatal yoksunluk sendromu olan prematüre bebek. Ege Tıp Dergisi 2014; 53: 102-5. 9. Wong S, Ordean A, Kahan M; Maternal Fetal Medicine Committee.; Family Physicians Advisory Committee.; MedicoLegal Committee.; Society of Obstetricians and Gynaecologists of Canada. Substance use in pregnancy. J Obstet Gynaecol Can 2011; 33: 367-84. [CrossRef] 10. Goler NC, Armstrong MA, Osejo VM, Hung YY, Haimowitz M, Caughey AB. Early start: a cost-beneficial perinatal substance abuse program. Obstet Gynecol 2012; 119: 102-10. [CrossRef] 11. Kaltenbach K, Holbrook AM, Coyle MG, Heil SH, Salisbury AL, Stine SM, et al. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication. Addiction 2012; 107: 45-52. [CrossRef] 12. Hudak ML, Tan RC; COMMITTEE ON DRUGS.; COMMITTEE ON FETUS AND NEWBORN.; American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics 2012; 129: e540-60. [CrossRef] 13. Laine K, Heikkinen T, Ekblad U, Kero P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry 2003; 60: 720-6. [CrossRef] 14. Feng Y, He X, Yang Y, Chao D, Lazarus LH, Xia Y. Currentresearch on opioid receptor function. Curr Drug Targets 2012; 13: 230-46. [CrossRef] 15. Barr